Design, recruitment, and microbiological considerations in human challenge studies
- 1 July 2015
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 15 (7) , 840-851
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-GuérinThe Journal of Infectious Diseases, 2012
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli VaccinesClinical and Vaccine Immunology, 2011
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusProceedings of the National Academy of Sciences, 2010
- Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in HumansInfection and Immunity, 2010
- Experimental hookworm infection: a randomized placebo‐controlled trial in asthmaClinical & Experimental Allergy, 2010
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 productionProceedings of the National Academy of Sciences, 2008
- Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccinesGut, 2008
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008